Stay updated on Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The esophageal cancer trial record is displayed with its study details, participant criteria, locations, outcome measures, publications, and supporting documents. The record identifies the study as completed and no longer recruiting participants.
    Difference
    100%
    Check dated 2026-11-07T16:22:35.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page. Its footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T16:34:47.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A notice announces that NIH is transitioning its terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:22:57.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2. The page otherwise continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T22:27:59.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T22:19:23.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The study record page now loads a 403 error instead of the trial details, indicating the page is inaccessible. This prevents users from viewing the study's design, eligibility, locations, and outcomes on that page.
    Difference
    18%
    Check dated 2026-09-19T20:18:42.000Z thumbnail image

Stay in the know with updates to Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Nivolumab and Ipilimumab in Esophageal Cancer Clinical Trial page.